Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elizabeta Dadić-Hero is active.

Publication


Featured researches published by Elizabeta Dadić-Hero.


European Psychiatry | 2010

PW01-221 - The relationship between personality traits and anxiety/depression levels in different types of substance abuse

S. Tatalovic Vorkapic; Elizabeta Dadić-Hero; Klementina Ruzic

To analyse the relationship between personality structure and emotional state of dyferent types of drug abusers, the objectives of this study were to examine: the levels of Eysencks personality dimensions and the levels of anxiety and depression of heroin addicts and recreate drug users; the relationship between personality and emotion variables; and differences between those two groups of subjects concerning their personality traits and emotional state. During their ambulatory admission, 288 (219 males and 69 females) patients were completed Eysencks Personality Questionnaire (EPQ R/A) and Becks Anxiety (BAI) and Depression Inventory (BDI). 191 of them were in the group of heroin addicts and 97 of them in the group of recreate drug users identified by the DSM-IV classification. Their averaged age was 22, ranged from 14 to 44. Significantly higher levels of psychoticism, neuroticism, criminality and addiction, that were determined in the group of heroin addicts, were significantly correlated with the higher levels of anxiety and depression. Higher extraversion and social conformity were determined in the group of recreate drug users who still had dispositions to resist of developing the addiction problem. Finally, even great differences in personality structure were determined between heroin addicts and recreate drug users, and even higher depression was found in the first group, there was no significant difference in the anxiety level between those two groups. The findings implied at the used measurement instruments here as the useful diagnostic tool that could provide with advantageous treatment directions.


European Psychiatry | 2011

P02-496 - Fluphenazine in the pregnancy

Elizabeta Dadić-Hero; T. Grahovac

Introduction Mental illness and pregnancy have always represented a great challenge to psychiatrists. There are certain risks when dealing with severe, long-term and chronic mental illness requiring continuous medication such as schizophrenia, which is always treated by antipsychotics. Objectives A 40-year-old pregnant woman, primipara has been suffering from schizophrenia for 24 and has been married for the last 15 years. Although the pregnancy was unplanned, the patient decided to give birth and was fully supported by her husband. From the very beginning of the illness the patient has been treated by an antipsychotic- flufenazine decanoate, every four weeks. During her life-long illness the patient was hospitalised three times and since the last hospitalization (17 years ago), the patient has continued the treatment on an outpatient basis.The pregnancy itself represented a risk for further psychic decompensation, while the risk of antipsychotic effect on the fetus was also present. A specific life situation of the patient required the introduction of different treatment types in order to assure an intensive monitoring and observation of the patient’s mental state. Besides depot medication, high-risk pregnancy required the introduction of additional supportive therapy (once a week). Conclusion Due to a high-risk pregnancy a regular collaborative approach and care of the psychiatrist, gynaecologist and GP were the prerequisites for successful treatment. During pregnancy the remission of schizophrenia was maintained, while during delivery and the postpartum period no relapse occurred. The patient had a full-term pregnancy and a natural childbirth. After delivery ablactation was suggested.


Annali dell'Istituto Superiore di Sanità | 2011

Proposal for a new detection method of substance abuse risk in Croatian adolescents

Sanja Tatalović Vorkapić; Elizabeta Dadić-Hero; Klementina Ruzic; Dobrica Rončević; Rajna Knez

One of the most important factors of successful substance abuse treatment is the early start of the same treatment. Recent selection method for identification of Croatian adolescents in the substance abuse risk that has been using drug tests from urine samples, has been simple and exact on the one hand, but on the other, has been very rare and usually guided by the pressure of parents or the court. Besides, such method presented the source of legal and ethical questions. So, the proposal of application of standardized psychological tests during systematic medical exams of Croatian adolescents at the age range of 15-22 years could help with the early detection of those adolescents who were in the substance abuse risk or already had the developed addiction problem.


Psychiatria Danubina | 2009

COMORBIDITY - A TROUBLESOME FACTOR IN PTSD TREATMENT

Elizabeta Dadić-Hero; Ines Torić; Paola Medved; Mirjana Graovac


Psychiatria Danubina | 2010

METABOLIC SYNDROME - THE CONSEQUENCE OF LIFELONG TREATMENT OF BIPOLAR AFFECTIVE DISORDER

Elizabeta Dadić-Hero; Klementina Ru; Tanja Grahovac; Mirjana Graovac


Psychiatria Danubina | 2011

Allergic reactions--outcome of sertraline and escitalopram treatments.

Elizabeta Dadić-Hero; Tanja Grahovac; Mirjana Graovac; Tija Žarković Palijan; Dubravka Šepić-Grahovac


Psychiatria Danubina | 2011

TREATMENT STRATEGY IN SCHIZOPHRENIA COMBINED WITH EATING DISORDER

Elizabeta Dadić-Hero; Tanja Grahovac; Toni Valković; Duška Petranović


Psychiatria Danubina | 2010

DEPRESSIVE DISORDER AND ALOPECIA

Tanja Grahovac; Klementina Ru; Elizabeta Dadić-Hero


Psychiatria Danubina | 2009

Olanzapine treatment in anorexia nervosa: case report.

Elizabeta Dadić-Hero; Mirjana Pernar; Milena Kabalin; Paola Medved


Psychiatria Danubina | 2010

Side-effects of generic.

Paola Medved; Elizabeta Dadić-Hero; Mirjana Graovac; Sanja Tatalović-Vorkapić; Ika Rončević Gržeta

Collaboration


Dive into the Elizabeta Dadić-Hero's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge